| Views | |
|---|---|
| The impact of fixed-dose anatihypertensive therapy on cardiorenal syndrome markers in patients with acute coronary syndrome and comorbidities | 28 |
| May 2026 | June 2026 | July 2026 | August 2026 | September 2026 | October 2026 | November 2026 | |
|---|---|---|---|---|---|---|---|
| The impact of fixed-dose anatihypertensive therapy on cardiorenal syndrome markers in patients with acute coronary syndrome and comorbidities | 0 | 0 | 0 | 0 | 0 | 20 | 8 |
| Views | |
|---|---|
| Pribylov_The impact_26.pdf | 6 |
| Views | |
|---|---|
| United States | 8 |
| Canada | 6 |
| Russia | 4 |
| United Arab Emirates | 1 |
| Bahrain | 1 |
| Switzerland | 1 |
| Colombia | 1 |
| France | 1 |
| United Kingdom | 1 |
| Ukraine | 1 |
| Views | |
|---|---|
| Ottawa | 6 |
| Houston | 3 |
| New Kensington | 2 |
| Ann Arbor | 1 |
| Basel | 1 |
| Bogotá | 1 |
| Bradford | 1 |
| Dubai | 1 |
| Greenville | 1 |
| Moscow | 1 |